Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

A Phase I Trial of Low-Dose Protracted Oral Clofarabine for the Treatment of Myelodysplastic Syndromes Patients Who Have Failed Frontline Therapy

Venkatesh K Rudrapatna, MD, Mark L. Wade, Ph.D., Andrew S Pierson, M.D., Christian T Shull, M.D., James P. Kushner, MD, Paul J Shami, M.D.

Blood (2010) 116 (21): 4975.

https://doi.org/10.1182/blood.V116.21.4975.4975

Published: 2010

Journal Articles

Cellular Distribution of Porphyrins In Porphyria Cutanea Tarda

John D Phillips, PhD, Hector A Bergonia, James P. Kushner, MD

Blood (2010) 116 (21): 165.

https://doi.org/10.1182/blood.V116.21.165.165

Published: 2010

Journal Articles

2 out of 3 isn't bad

James P. Kushner

Blood (2010) 115 (17): 3425–3426.

https://doi.org/10.1182/blood-2010-01-264838

Published: 2010

Journal Articles

Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi

Curry L. Koening, Jennifer C. Miller, Jenifer M. Nelson, Diane M. Ward, James P. Kushner, Linda K. Bockenstedt, Janis J. Weis, Jerry Kaplan, Ivana De Domenico

Blood (2009) 114 (9): 1913–1918.

https://doi.org/10.1182/blood-2009-03-209577

Published: 2009

Journal Articles

Down-regulation of hepcidin in porphyria cutanea tarda

Richard S. Ajioka, John D. Phillips, Robert B. Weiss, Diane M. Dunn, Maria W. Smit, Sean C. Proll, Michael G. Katze, James P. Kushner

Blood (2008) 112 (12): 4723–4728.

https://doi.org/10.1182/blood-2008-02-138222

Published: 2008

Includes: Supplemental data

Journal Articles

The Uroporphomethene Inhibitor Causitive for Porphyria Cutanea Tarda (PCT) Is Generated by Oxidation of Hydroxymethylbilane (HMB)

John D Phillips, PhD, Hector A Bergonia, Christopher A Reilly, Michael R Franklin, James P Kushner

Blood (2008) 112 (11): 3454.

https://doi.org/10.1182/blood.V112.11.3454.3454

Published: 2008

Journal Articles

Iron Chelation by Deferoxamine Induces Autophagy

Ivana De Domenico, Diane McVey Ward, PhD, James P. Kushner, Jerry Kaplan, Ph.D.

Blood (2008) 112 (11): 117.

https://doi.org/10.1182/blood.V112.11.117.117

Published: 2008

Journal Articles

Hepcidin-Independent Regulation of Dietary Iron Absorption

Richard S. Ajioka, PhD, Ivana De Domenico, James P. Kushner

Blood (2008) 112 (11): 3853.

https://doi.org/10.1182/blood.V112.11.3853.3853

Published: 2008

Journal Articles

Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations

Ivana De Domenico, Michael B. Vaughn, Donghoon Yoon, James P. Kushner, Diane M. Ward, Jerry Kaplan

Blood (2007) 110 (10): 3780–3783.

https://doi.org/10.1182/blood-2007-07-100248

Published: 2007

Journal Articles

Congenital erythropoietic porphyria due to a mutation in GATA1 : the first trans -acting mutation causative for a human porphyria

John D. Phillips, David P. Steensma, Michael A. Pulsipher, Gerald J. Spangrude, James P. Kushner

Blood (2006) 109 (6): 2618–2621.

https://doi.org/10.1182/blood-2006-06-022848

Published: 2006

Journal Articles

HAMP and HVJ as Candidate Modifier Genes in Type1 Hereditary Hemochromatosis with High Iron Burden and in Porphyria Cutanea Tarda (PCT).

Richard S. Ajioka, PhD, John D. Phillips, Ph.D., Robert B. Weiss, Ph.D., Diane M. Dunn, M.S., James P. Kushner, M.D.

Blood (2006) 108 (11): 1544.

https://doi.org/10.1182/blood.V108.11.1544.1544

Published: 2006

Journal Articles

An Inhibitor of Uroporphyrinogen Decarboxylase (URO-D) Causes Porphyria Cutanea Tarda (PCT).

James P. Kushner, MD, Michael R. Franklin, PhD, Christopher P. Reilly, PhD, Hector A. Bergonia, MS, John D. Phillips, PhD

Blood (2006) 108 (11): 270.

https://doi.org/10.1182/blood.V108.11.270.270

Published: 2006

Journal Articles

Mechanisms Regulating Iron Absorption over a Wide Range of Dietary Iron Content in the Mouse.

Richard S. Ajioka, PhD, Ryan R. Gillespie, BS, James P. Kushner, MD

Blood (2005) 106 (11): 3578.

https://doi.org/10.1182/blood.V106.11.3578.3578

Published: 2005

Journal Articles

Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation.

John D. Phillips, PhD, David P. Steensma, MD, Gerald J. Spangrude, PhD, James P. Kushner, MD

Blood (2005) 106 (11): 515.

https://doi.org/10.1182/blood.V106.11.515.515

Published: 2005

Journal Articles

Crystal Structure of Coproporphyrinogen Oxidase (CPO).

John D. Phillips, PhD, Frank G. Whitby, PhD, Christopher P. Hill, PhD, James P. Kushner, MD

Blood (2004) 104 (11): 52.

https://doi.org/10.1182/blood.V104.11.52.52

Published: 2004

Journal Articles

Identification of a novel mutation (C321X) in HJV

Franklin W. Huang, Isabel Rubio-Aliaga, James P. Kushner, Nancy C. Andrews, Mark D. Fleming

Blood (2004) 104 (7): 2176–2177.

https://doi.org/10.1182/blood-2004-01-0400

Published: 2004

Journal Articles

Rebuttal to Beutler

Richard S. Ajioka, James P. Kushner

Blood (2003) 101 (9): 3358.

https://doi.org/10.1182/blood-2003-01-0040

Published: 2003

Journal Articles

Clinical consequences of iron overload in hemochromatosis homozygotes

Richard S. Ajioka, James P. Kushner

Blood (2003) 101 (9): 3351–3353.

https://doi.org/10.1182/blood-2002-11-3453

Published: 2003

Journal Articles

Regulation of iron absorption in Hfe mutant mice

Richard S. Ajioka, Joanne E. Levy, Nancy C. Andrews, James P. Kushner

Blood (2002) 100 (4): 1465–1469.

https://doi.org/10.1182/blood-2001-11-0037

Published: 2002

Journal Articles

Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis

Wolf-K. Hofmann, Xiang-Jun Tong, Richard S. Ajioka, James P. Kushner, H. Phillip Koeffler

Blood (2002) 100 (3): 1099–1100.

https://doi.org/10.1182/blood-2002-04-1077

Published: 2002

NARROW

A Phase I Trial of Low-Dose Protracted Oral Clofarabine for the Treatment of Myelodysplastic Syndromes Patients Who Have Failed Frontline Therapy

Cellular Distribution of Porphyrins In Porphyria Cutanea Tarda

2 out of 3 isn't bad

Toll-like receptors mediate induction of hepcidin in mice infected with Borrelia burgdorferi

Down-regulation of hepcidin in porphyria cutanea tarda

The Uroporphomethene Inhibitor Causitive for Porphyria Cutanea Tarda (PCT) Is Generated by Oxidation of Hydroxymethylbilane (HMB)

Iron Chelation by Deferoxamine Induces Autophagy

Hepcidin-Independent Regulation of Dietary Iron Absorption

Zebrafish as a model for defining the functional impact of mammalian ferroportin mutations

Congenital erythropoietic porphyria due to a mutation in GATA1 : the first trans -acting mutation causative for a human porphyria

HAMP and HVJ as Candidate Modifier Genes in Type1 Hereditary Hemochromatosis with High Iron Burden and in Porphyria Cutanea Tarda (PCT).

An Inhibitor of Uroporphyrinogen Decarboxylase (URO-D) Causes Porphyria Cutanea Tarda (PCT).

Mechanisms Regulating Iron Absorption over a Wide Range of Dietary Iron Content in the Mouse.

Congenital Erythropoietic Porphyria, β-Thalassemia Intermedia and Thrombocytopenia Due to a GATA1 Mutation.

Crystal Structure of Coproporphyrinogen Oxidase (CPO).

Identification of a novel mutation (C321X) in HJV

Rebuttal to Beutler

Clinical consequences of iron overload in hemochromatosis homozygotes

Regulation of iron absorption in Hfe mutant mice

Mutation analysis of transferrin-receptor 2 in patients with atypical hemochromatosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only